Skip to main content
Full access
Letter to the Editor
Published Online: 1 February 2010

Increased Cardiac Death or Decreased Motor Vehicle Accidents?

To the Editor: It was with great interest that we read the article by Madelyn S. Gould, Ph.D., M.P.H., et al. (1), published in the September 2009 issue of the Journal. In a case-control study, the authors arrived at the conclusion that there may be an association between the use of prescribed stimulants and an increased risk of sudden cardiac death. The comparison they used to establish this association was a group of youths who perished in motor vehicle accidents. The authors justified this decision by citing evidence that stimulant users were not likely to be overrepresented within this group.
In finding a higher percentage of stimulant users in the cardiac death group compared with the percentage of stimulant users in the motor vehicle victim group, Dr. Gould et al. made the interpretation that stimulants are likely to increase the risk of cardiac death. However, there is an alternative interpretation that deserves consideration and that, perhaps, has more support in the recent literature. There is a burgeoning interest among clinicians and researchers regarding the effect of attention deficit hyperactivity disorder (ADHD) on driving behavior. The evidence is strong that ADHD is associated with an increased risk of motor vehicle accidents (2) and that stimulants significantly attenuate this risk (2, 3). Thus, it may not be that stimulants were overrepresented in the cardiac death group. It may just appear so because they actually lower the risk of motor vehicle accidents in adolescents and young adults with ADHD and therefore were underrepresented in the comparator group.
This study has attracted significant media attention and has already affected our clinical practice in the short time since its publication. We hope that it will not result in hasty conclusions, driving (quite literally) patients toward the risks of untreated ADHD out of a possibly unfounded fear of treatment. In our view, the tiny risk of cardiac complications from stimulant treatment of a high-risk condition such as ADHD is more than outweighed by the benefits accrued in fewer motor vehicle accidents.

Footnote

This letter was accepted for publication in October 2009.

References

1.
Gould MS, Walsh BT, Munfakh JL, Kleinman M, Duan N, Olfson M, Greenhill L, Cooper T: Sudden death and use of stimulant medications in youths. Am J Psychiatry 2009; 166:992–1001
2.
Barkley RA, Cox D: A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J Safety Res 2007; 38:113–128
3.
Verster JC, Bekker EM, de Roos M, Minova A, Eijken EJ, Kooij JJ, Buitelaar JK, Kenemans JL, Verbaten MN, Olivier B, Volkerts ER: Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial. J Psychopharmacol 2008; 22:230–237

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 213
PubMed: 20123923

History

Accepted: October 2009
Published online: 1 February 2010
Published in print: February 2010

Authors

Details

Anthony L. Rostain, M.D., M.A.

Competing Interests

Dr. Blume is the recipient of an American Psychiatric Institute for Research and Education/Janssen Research Scholar Fellowship; Dr. Rostain has served as a consultant to Ortho-McNeil and Shire; he has also served on the speaker's bureau of Eli Lilly, Ortho-McNeil, and Shire.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share